Replies to post #115744 on Biotech Values

[pollyvonwog]

If NVS thinks tL has little chance of approval then they risk little downside and obtain further upside on mC.

If NVS thinks this than so does MNTA then what would be the impetus for MNTA to reduce its Copaxone share :)

[dav1234]

i see your point,i doubt NVS would entertain that until they had some clarity on patent issue for mC, could work since it would not materially affect NVS.